Novo Nordisk A/S (NVO)
44.74
-1.06
(-2.31%)
USD |
NYSE |
May 15, 16:00
44.45
-0.29
(-0.65%)
After-Hours: 20:00
Novo Nordisk Market Cap : 198.33B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 281.60B |
| GSK Plc | 99.71B |
| Johnson & Johnson | 545.74B |
| Eli Lilly & Co. | 896.13B |
| Lexicon Pharmaceuticals, Inc. | 990.56M |
Market Cap Related Metrics
| PE Ratio | 10.50 |
| PS Ratio | 3.909 |
| PEG Ratio | 0.4008 |
| Price to Book Value | 8.355 |
| Price to Free Cash Flow | 103.88 |
| Price | 44.74 |
| Earnings Yield | 9.52% |
| PEGY Ratio | 0.3474 |
| Operating PE Ratio | 8.600 |
| Normalized PE Ratio | 10.50 |